Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 12 September 2024
      New mandate, new opportunity: A competitiveness strategy for European life sciences
 
 
Learn more here.
 

Described by Time Magazine as “not just an election year. [But] perhaps the election year”, in 2024 an estimated 49% of the world’s population are going to the polls.

In Europe, a new parliament have taken their seats, and the European Commission’s President, Ursula von der Leyen, has laid out the political guidelines for the next mandate.

The life sciences sector is unique. It can deliver scientific and medical breakthroughs with the power to transform the lives of patients while driving Europe’s economic growth, resilience and security. It is, however, under pressure.

Read more →
 
 
      News
 
  09 September 2024 EFPIA response to Mario Draghi EU competitiveness report

EFPIA welcomes recognition of the innovative pharmaceutical sector’s importance to EU competitiveness and calls for...

Read more →
 
 
 
  02 September 2024 Thomas Gelin joins EFPIA as Executive Director, International Affairs

With Europe’s competitive edge at the top of the political agenda, EFPIA is delighted to announce the appointment of...

Read more →
 
 
 
      Blogs
 
  10 September 2024 Data anonymisation: balancing privacy and progress

A new visual aid explores the trade-offs researchers face in protecting patients’ identities and sharing data to advance...

Read more →
 
 
 
  09 September 2024 Measuring the value of data disclosure

Industry is committed to responsible sharing of clinical trial data to support the advancement of public health

Read more →
 
 
 
  03 September 2024 Unmet Medical Need: Preventing childhood blindness (Guest blog)

A story of innovation, collaboration, and determination to solve a complex medical and scientific challenge in a highly...

Read more →
 
 
 
      Innovative Health Initiative celebrates 200 project

Hitting the 200 project milestone shows the strength of the public-private partnership approach pioneered by the Innovative Medicines Initiative and built on by IHI.

Learn more about the IHI initiative here.

 
 
 
      Events
 
 
24 SEP 2024
  DIA Medical Information & Communications Conference London, UK

The 2024 DIA Medical Information and Communications Conference is designed for medical information professionals and...

Learn more →
 
 
 
26 SEP 2024
  Bridging the Gap: The New Pan-European Observatory as a Catalyst for EHDS Implementation... Vienna and online

Explore how the H2O Pan-European Observatory can play a pivotal role in aligning digitally captured patient outcomes...

Learn more →
 
 
      What we are reading
Health Data Ethics & Regulatory Frameworks in Rare Disease Research 11 September 2024  (Future Learn) Read more →
Draghi report touts path to pull EU pharma from ‘slow agony’ 10 September 2024  (Euronews) Read more →
How “Team Europe” Can Co-Create the Healthcare R&D Framework of Tomorrow 08 August 2024  (DIA Global Forum) Read more →
Rare Barometer survey launched on rare diseases and social participation 17 July 2024  (EURORDIS) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe